Article ID Journal Published Year Pages File Type
5824662 Clinical Therapeutics 2016 13 Pages PDF
Abstract
Among HR+/HER2− mBC patients with multiple metastatic sites, everolimus-based therapy was associated with better real-world effectiveness than endocrine monotherapy or chemotherapy.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Medicine and Dentistry (General)
Preview
Effectiveness of Everolimus Versus Endocrine Monotherapy or Chemotherapy Among HR+/HER2− mBC Patients With Multiple Metastatic Sites
Authors
, , , , , , , ,